Consensus Ratings for Navidea Biopharmaceuticals (NYSE:NAVB) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||$2.00 (14.94% upside)|
Analysts' Ratings History for Navidea Biopharmaceuticals (NYSE:NAVB)
(Data available from 12/18/2012 forward)
|5/22/2014||Aegis||Lower Price Target||$2.50 -> $2.00||View|| |